1 of 4
Drug Abuse Testing Market Overview:
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Drug Abuse Testing Key Market Segments:
By Product & Services
Analyzers
Consumables
Rapid Testing Devices
Laboratory Services
By Sample Type
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
By End User
Workplaces & Schools
Criminal Justice Systems and Law Enforcement Agencies
Research Laboratories
Hospitals
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
Key Market Players:
Drägerwerk AG & Co
Abbott Laboratories
Hoffmann-La Roche AG
Bio Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.
Laboratory Corporation of America Holdings
The other players in the value chain include (profiles not included in the report):
OraSure
Alfa Scientific Designs
Lifeloc
MPD, Inc
Premier Biotech
Shimadzu
Psychemedics
SureHire
CannAmm
Omega Laboratories
The global drug abuse testing market was valued at $6,244 million in 2017 and is expected to reach $11,833 million by 2025, registering a CAGR of 8.2% from 2018 to 2025.
A drug test is primarily performed to confirm the presence of one or more illegal or prescription drugs in a person’s urine, blood, saliva, hair, or sweat. The test is performed by using the samples such as urine, hair, blood, saliva, and others. Among these urine sample is the most widely preferred owing to the advantages it offers, such as lower test cost, availability of more sample, and availability of point-of-care tests. Drug testing offers a critical adjunct to clinical care and substance use. The most often tested drugs include marijuana, opioids, cocaine, morphine, and others. Drug tests are increasingly being adopted by sports organizations, employers, forensic purposes, and several other applications.
The surge in consumption of alcohol and illicit drugs across the globe is one of the major drivers for the drug testing market. In addition, technological advancements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug abuse monitoring further boost the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market. On the contrary, emerging markets such as the Asia-Pacific and LAMEA, provide lucrative growth opportunities for the market.
The global drug abuse testing market is segmented based on products & services, sample type, end user, and region. Based on products & services, it is divided into equipment, rapid testing devices (RTD), consumables, and laboratory services. Based on equipment, it is further categorized into immunoassay analyzers, chromatography instruments, and breath analyzers. Based on RTD, it is bifurcated into urine testing devices and oral fluid/saliva testing devices. Based on consumables, it is divided into assay kits, sample collection cups, calibrators & controls, and other consumables. Based on sample type, the market is divided into urine sample, breath sample, oral fluid sample, hair sample, and others.
Based on end user, it is segmented into workplace & school, drug testing laboratories, criminal justice & law enforcement agencies, hospitals, pain management centers, and personal users. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for drug abuse testing market:
The study provides an in-depth analysis of the global drug abuse testing market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Drug Abuse Testing Key Market Segments:
By Product & Services
Analyzers
Consumables
Rapid Testing Devices
Laboratory Services
By Sample Type
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
By End User
Workplaces & Schools
Criminal Justice Systems and Law Enforcement Agencies
Research Laboratories
Hospitals
By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Turkey
Rest of LAMEA
Key Market Players:
Drägerwerk AG & Co
Abbott Laboratories
Hoffmann-La Roche AG
Bio Rad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.
Laboratory Corporation of America Holdings
The other players in the value chain include (profiles not included in the report):
OraSure
Alfa Scientific Designs
Lifeloc
MPD, Inc
Premier Biotech
Shimadzu
Psychemedics
SureHire
CannAmm
Omega Laboratories
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for the stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Stringent government regulations regarding drug abuse
3.5.1.2. Rise in awareness against drug abuse
3.5.1.3. Development of novel drug testing equipment
3.5.2. Restraints
3.5.2.1. Consideration of drug abuse testing as a violation of rights
3.5.2.2. Possible manipulation of drug screening tests
3.5.3. Opportunities
3.5.3.1. Development of novel drug screening tests
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Analyzers
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Immunoassay analyzers
4.2.4.1. Market size and forecast
4.2.5. Chromatography analyzers
4.2.5.1. Market size and forecast
4.2.6. Breath analyzers
4.2.6.1. Market size and forecast
4.3. Rapid Testing Devices
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Urine testing devices
4.3.4.1. Market size and forecast
4.3.4.2. Urine testing devices, by type market size and forecast
4.3.4.2.1. Market size and forecast
4.3.5. Oral fluid testing devices
4.3.5.1. Market size and forecast
4.4. Consumables
4.4.1. Key trends and opportunities
4.4.1.1. Market size and forecast
4.4.2. Market analysis, by country
4.4.2.1. Assay kits
4.4.2.1.1. Market size and forecast
4.4.2.2. Sample collection cups
4.4.2.2.1. Market size and forecast
4.4.2.3. Calibrators and controls
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.5. Laboratory Services
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Urine
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Oral Fluid
5.2.3.1. Market size and forecast
5.2.4. Market analysis, by country
5.2.5. Breath
5.2.5.1. Market size and forecast
5.2.6. Market analysis, by country
5.2.7. Hair
5.2.7.1. Market size and forecast
5.2.8. Market analysis, by country
5.2.9. Other Samples
5.2.9.1. Market size and forecast
5.2.10. Market analysis, by country
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Workplaces and Schools
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Criminal Justice Systems and Law Enforcement Agencies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research laboratories
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Hospitals
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product & service
7.2.2.2. U.S. market size and forecast, by sample type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product & service
7.2.2.5. Canada market size and forecast, by sample type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product & service
7.2.2.8. Mexico market size and forecast, by sample type
7.2.2.9. Mexico market size and forecast, by end user
7.2.2.10. North America market size and forecast, by product & service
7.2.3. North America market size and forecast, by sample type
7.2.4. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product & service
7.3.2.2. Germany market size and forecast, by sample type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. UK market size and forecast, by product & service
7.3.2.5. UK market size and forecast, by sample type
7.3.2.6. UK market size and forecast, by end user
7.3.2.7. France market size and forecast, by product & service
7.3.2.8. France market size and forecast, by sample type
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Rest of Europe market size and forecast, by product & service
7.3.2.11. Rest of Europe market size and forecast, by sample type
7.3.2.12. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by sample type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product & service
7.4.2.2. Japan market size and forecast, by sample type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product & service
7.4.2.5. China market size and forecast, by sample type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product & service
7.4.2.8. India market size and forecast, by sample type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product & service
7.4.2.11. Australia market size and forecast, by sample type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product & service
7.4.2.14. Rest of Asia-Pacific market size and forecast, by sample type
7.4.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.4. Asia-Pacific market size and forecast, by product & service
7.4.5. Asia-Pacific market size and forecast, by sample type
7.4.6. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product & service
7.5.2.2. Brazil market size and forecast, by sample type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. South Africa market size and forecast, by product & service
7.5.2.5. South Africa market size and forecast, by sample type
7.5.2.6. South Africa market size and forecast, by end user
7.5.2.7. Saudi Arabia market size and forecast, by product & service
7.5.2.8. Saudi Arabia market size and forecast, by sample type
7.5.2.9. Saudi Arabia market size and forecast, by end user
7.5.2.10. Turkey market size and forecast, by product & service
7.5.2.11. Turkey market size and forecast, by sample type
7.5.2.12. Turkey market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product & service
7.5.2.14. Rest of LAMEA market size and forecast, by sample type
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by sample type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIO-RAD LABORATORIES INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Product portfolio
8.3. DANAHER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. DRGERWERK AG & CO. KGAA
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. EXPRESS DIAGNOSTICS INTERNATIONAL INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. QUEST DIAGNOSTICS INCORPORATED
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. SIEMENS AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. THERMO FISHER SCIENTIFIC INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
1.1. Report description
1.2. Key benefits for the stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Stringent government regulations regarding drug abuse
3.5.1.2. Rise in awareness against drug abuse
3.5.1.3. Development of novel drug testing equipment
3.5.2. Restraints
3.5.2.1. Consideration of drug abuse testing as a violation of rights
3.5.2.2. Possible manipulation of drug screening tests
3.5.3. Opportunities
3.5.3.1. Development of novel drug screening tests
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Analyzers
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Immunoassay analyzers
4.2.4.1. Market size and forecast
4.2.5. Chromatography analyzers
4.2.5.1. Market size and forecast
4.2.6. Breath analyzers
4.2.6.1. Market size and forecast
4.3. Rapid Testing Devices
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Urine testing devices
4.3.4.1. Market size and forecast
4.3.4.2. Urine testing devices, by type market size and forecast
4.3.4.2.1. Market size and forecast
4.3.5. Oral fluid testing devices
4.3.5.1. Market size and forecast
4.4. Consumables
4.4.1. Key trends and opportunities
4.4.1.1. Market size and forecast
4.4.2. Market analysis, by country
4.4.2.1. Assay kits
4.4.2.1.1. Market size and forecast
4.4.2.2. Sample collection cups
4.4.2.2.1. Market size and forecast
4.4.2.3. Calibrators and controls
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.5. Laboratory Services
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Urine
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.3. Oral Fluid
5.2.3.1. Market size and forecast
5.2.4. Market analysis, by country
5.2.5. Breath
5.2.5.1. Market size and forecast
5.2.6. Market analysis, by country
5.2.7. Hair
5.2.7.1. Market size and forecast
5.2.8. Market analysis, by country
5.2.9. Other Samples
5.2.9.1. Market size and forecast
5.2.10. Market analysis, by country
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Workplaces and Schools
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Criminal Justice Systems and Law Enforcement Agencies
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Research laboratories
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Hospitals
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product & service
7.2.2.2. U.S. market size and forecast, by sample type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product & service
7.2.2.5. Canada market size and forecast, by sample type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product & service
7.2.2.8. Mexico market size and forecast, by sample type
7.2.2.9. Mexico market size and forecast, by end user
7.2.2.10. North America market size and forecast, by product & service
7.2.3. North America market size and forecast, by sample type
7.2.4. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product & service
7.3.2.2. Germany market size and forecast, by sample type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. UK market size and forecast, by product & service
7.3.2.5. UK market size and forecast, by sample type
7.3.2.6. UK market size and forecast, by end user
7.3.2.7. France market size and forecast, by product & service
7.3.2.8. France market size and forecast, by sample type
7.3.2.9. France market size and forecast, by end user
7.3.2.10. Rest of Europe market size and forecast, by product & service
7.3.2.11. Rest of Europe market size and forecast, by sample type
7.3.2.12. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product & service
7.3.4. Europe market size and forecast, by sample type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product & service
7.4.2.2. Japan market size and forecast, by sample type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product & service
7.4.2.5. China market size and forecast, by sample type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product & service
7.4.2.8. India market size and forecast, by sample type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product & service
7.4.2.11. Australia market size and forecast, by sample type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product & service
7.4.2.14. Rest of Asia-Pacific market size and forecast, by sample type
7.4.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.4. Asia-Pacific market size and forecast, by product & service
7.4.5. Asia-Pacific market size and forecast, by sample type
7.4.6. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product & service
7.5.2.2. Brazil market size and forecast, by sample type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. South Africa market size and forecast, by product & service
7.5.2.5. South Africa market size and forecast, by sample type
7.5.2.6. South Africa market size and forecast, by end user
7.5.2.7. Saudi Arabia market size and forecast, by product & service
7.5.2.8. Saudi Arabia market size and forecast, by sample type
7.5.2.9. Saudi Arabia market size and forecast, by end user
7.5.2.10. Turkey market size and forecast, by product & service
7.5.2.11. Turkey market size and forecast, by sample type
7.5.2.12. Turkey market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product & service
7.5.2.14. Rest of LAMEA market size and forecast, by sample type
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product & service
7.5.4. LAMEA market size and forecast, by sample type
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIO-RAD LABORATORIES INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Product portfolio
8.3. DANAHER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. DRGERWERK AG & CO. KGAA
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. EXPRESS DIAGNOSTICS INTERNATIONAL INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. F. HOFFMANN-LA ROCHE LTD. (GENENTECH INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. QUEST DIAGNOSTICS INCORPORATED
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. SIEMENS AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. THERMO FISHER SCIENTIFIC INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 4
According to this report titled, 'Drug Abuse Testing Market by Product & Service, Sample Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025' the global drug abuse testing market was valued at $6,244 million in 2017, and is projected to reach $11,833 million by 2025, growing at a CAGR of 8.2% from 2018 to 2025.
Drug abuse test is a technique used to determine an individuals scope and degree of drug abuse/alcohol consumption. The test is usually performed for drugs of abuse such as marijuana, cocaine, amphetamines, benzodiazepines, PCP, opioids (narcotics), and others. Overuse of prescribed & illicit drugs is the major driver for the drug abuse testing market.
The drug abuse testing market is growing at a significant pace due to surge in incidence of drug abuse across the globe as well as rise in strict guidelines by the government agencies against the use of drug abuse in various fields including sports, schools, workplaces, and others. Further, leading manufacturers are focusing on the technological advancements in drug abuse test devices that contribute to the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market.
The consumables segment by product & service generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the use of different consumables for drug testing such as assay kits, sample collection cups, calibrators and controls, and others.
Based on sample type, the market is classified into urine, oral fluid (saliva), breath, hair, and other samples. Urine sample generated the highest revenue among all the samples. Urine testing has been well established in forensic toxicology with added versatility and easier sample collection.
Key Findings of the Drug Abuse Testing Market:
Based on product, the consumables segment dominated the global drug abuse testing market in 2017 and is expected to maintain this trend during the forecast period.
Based on sample type, the hair sample is expected to register the highest CAGR of 12.0% from 2018 to 2025.
Based on end user, the criminal justice systems and law enforcement agencies segment is expected to register the highest CAGR of 10.2% from 2018 to 2025.
U.S. generated the highest revenue in the global drug abuse testing market in 2017, accounting for more than half of the market in North America.
Asia-Pacific is anticipated to experience rapid growth during the forecast period.
North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for the development of more precise and accurate drug abuse testing devices. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in awareness regarding the use of drug abuse tests devices by the employers and law enforcement agencies.
The report provides an extensive competitive analysis and profiles of the key market players, such as Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. The other key players included in the value chain analysis (but not included in the report) are OraSure, Alfa Scientific Designs, Lifeloc, MPD, Inc., Premier Biotech, Shimadzu, Psychemedics, SureHire, CannAmm, and Omega Laboratories.
Drug abuse test is a technique used to determine an individuals scope and degree of drug abuse/alcohol consumption. The test is usually performed for drugs of abuse such as marijuana, cocaine, amphetamines, benzodiazepines, PCP, opioids (narcotics), and others. Overuse of prescribed & illicit drugs is the major driver for the drug abuse testing market.
The drug abuse testing market is growing at a significant pace due to surge in incidence of drug abuse across the globe as well as rise in strict guidelines by the government agencies against the use of drug abuse in various fields including sports, schools, workplaces, and others. Further, leading manufacturers are focusing on the technological advancements in drug abuse test devices that contribute to the market growth. However, lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries restrict the growth of the global market.
The consumables segment by product & service generated the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the use of different consumables for drug testing such as assay kits, sample collection cups, calibrators and controls, and others.
Based on sample type, the market is classified into urine, oral fluid (saliva), breath, hair, and other samples. Urine sample generated the highest revenue among all the samples. Urine testing has been well established in forensic toxicology with added versatility and easier sample collection.
Key Findings of the Drug Abuse Testing Market:
Based on product, the consumables segment dominated the global drug abuse testing market in 2017 and is expected to maintain this trend during the forecast period.
Based on sample type, the hair sample is expected to register the highest CAGR of 12.0% from 2018 to 2025.
Based on end user, the criminal justice systems and law enforcement agencies segment is expected to register the highest CAGR of 10.2% from 2018 to 2025.
U.S. generated the highest revenue in the global drug abuse testing market in 2017, accounting for more than half of the market in North America.
Asia-Pacific is anticipated to experience rapid growth during the forecast period.
North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for the development of more precise and accurate drug abuse testing devices. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in awareness regarding the use of drug abuse tests devices by the employers and law enforcement agencies.
The report provides an extensive competitive analysis and profiles of the key market players, such as Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. The other key players included in the value chain analysis (but not included in the report) are OraSure, Alfa Scientific Designs, Lifeloc, MPD, Inc., Premier Biotech, Shimadzu, Psychemedics, SureHire, CannAmm, and Omega Laboratories.
Note: Product cover images may vary from those shown
4 of 4
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
